Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 2
1961 1
1962 2
1963 1
1964 1
1965 1
1966 1
1967 1
1968 3
1969 4
1970 2
1971 4
1972 4
1973 1
1974 2
1975 6
1976 5
1977 2
1978 4
1979 6
1980 8
1981 8
1982 11
1983 8
1984 8
1985 4
1986 9
1987 7
1988 6
1989 8
1990 17
1991 18
1992 21
1993 17
1994 19
1995 10
1996 8
1997 12
1998 14
1999 11
2000 22
2001 22
2002 21
2003 27
2004 14
2005 24
2006 24
2007 23
2008 36
2009 39
2010 38
2011 33
2012 47
2013 48
2014 49
2015 40
2016 59
2017 61
2018 59
2019 48
2020 64
2021 82
2022 92
2023 90
2024 35

Text availability

Article attribute

Article type

Publication date

Search Results

1,230 results

Results by year

Filters applied: . Clear all
Page 1
Transplantation of intestinal organoids into a mouse model of colitis.
Watanabe S, Kobayashi S, Ogasawara N, Okamoto R, Nakamura T, Watanabe M, Jensen KB, Yui S. Watanabe S, et al. Among authors: okamoto r. Nat Protoc. 2022 Mar;17(3):649-671. doi: 10.1038/s41596-021-00658-3. Epub 2022 Feb 2. Nat Protoc. 2022. PMID: 35110738 Review.
Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy.
Correia AL, Guimaraes JC, Auf der Maur P, De Silva D, Trefny MP, Okamoto R, Bruno S, Schmidt A, Mertz K, Volkmann K, Terracciano L, Zippelius A, Vetter M, Kurzeder C, Weber WP, Bentires-Alj M. Correia AL, et al. Among authors: okamoto r. Nature. 2021 Jun;594(7864):566-571. doi: 10.1038/s41586-021-03614-z. Epub 2021 Jun 2. Nature. 2021. PMID: 34079127
Glucocorticoids promote breast cancer metastasis.
Obradović MMS, Hamelin B, Manevski N, Couto JP, Sethi A, Coissieux MM, Münst S, Okamoto R, Kohler H, Schmidt A, Bentires-Alj M. Obradović MMS, et al. Among authors: okamoto r. Nature. 2019 Mar;567(7749):540-544. doi: 10.1038/s41586-019-1019-4. Epub 2019 Mar 13. Nature. 2019. PMID: 30867597
Inferring and perturbing cell fate regulomes in human brain organoids.
Fleck JS, Jansen SMJ, Wollny D, Zenk F, Seimiya M, Jain A, Okamoto R, Santel M, He Z, Camp JG, Treutlein B. Fleck JS, et al. Among authors: okamoto r. Nature. 2023 Sep;621(7978):365-372. doi: 10.1038/s41586-022-05279-8. Epub 2022 Oct 5. Nature. 2023. PMID: 36198796 Free PMC article.
Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expression.
Lama L, Adura C, Xie W, Tomita D, Kamei T, Kuryavyi V, Gogakos T, Steinberg JI, Miller M, Ramos-Espiritu L, Asano Y, Hashizume S, Aida J, Imaeda T, Okamoto R, Jennings AJ, Michino M, Kuroita T, Stamford A, Gao P, Meinke P, Glickman JF, Patel DJ, Tuschl T. Lama L, et al. Among authors: okamoto r. Nat Commun. 2019 May 21;10(1):2261. doi: 10.1038/s41467-019-08620-4. Nat Commun. 2019. PMID: 31113940 Free PMC article.
[Organoid-based therapy].
Okamoto R, Mizutani T, Shimizu H. Okamoto R, et al. Nihon Shokakibyo Gakkai Zasshi. 2023;120(12):964-972. doi: 10.11405/nisshoshi.120.964. Nihon Shokakibyo Gakkai Zasshi. 2023. PMID: 38072459 Japanese. No abstract available.
The gut microbiota-induced kynurenic acid recruits GPR35-positive macrophages to promote experimental encephalitis.
Miyamoto K, Sujino T, Harada Y, Ashida H, Yoshimatsu Y, Yonemoto Y, Nemoto Y, Tomura M, Melhem H, Niess JH, Suzuki T, Suzuki T, Suzuki S, Koda Y, Okamoto R, Mikami Y, Teratani T, Tanaka KF, Yoshimura A, Sato T, Kanai T. Miyamoto K, et al. Among authors: okamoto r. Cell Rep. 2023 Aug 29;42(8):113005. doi: 10.1016/j.celrep.2023.113005. Epub 2023 Aug 16. Cell Rep. 2023. PMID: 37590143 Free article.
Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study.
Robak T, Jin J, Pylypenko H, Verhoef G, Siritanaratkul N, Drach J, Raderer M, Mayer J, Pereira J, Tumyan G, Okamoto R, Nakahara S, Hu P, Appiani C, Nemat S, Cavalli F; LYM-3002 investigators. Robak T, et al. Among authors: okamoto r. Lancet Oncol. 2018 Nov;19(11):1449-1458. doi: 10.1016/S1470-2045(18)30685-5. Epub 2018 Oct 19. Lancet Oncol. 2018. PMID: 30348538 Clinical Trial.
In Science Journals.
Norton M, Zahn LM, Stajic J, Yeston J, Jiang D, Smith KT, Vinson V, Okamoto R, Purnell BA, Scanlon ST, Hines PJ, Stern P, Suleymanov Y, Osborne IS, Wong W, Olingy C, Alderton G, Sugden AM. Norton M, et al. Among authors: okamoto r. Science. 2022 Mar 4;375(6584):987-989. doi: 10.1126/science.ada1662. Epub 2022 Mar 3. Science. 2022. PMID: 35239379
1,230 results